logo

For the Inventor, By the Inventor

Calgary, Canada

Oncolytics Biotech Inc.


USPTO Granted Patents = 64



Trademarks = 4

Forward Citations = 647

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Matthew C Coffey (61 out of 64 patents)

silverMedal Bradley G Thompson (32 out of 76 patents)

bronzeMedal James Strong (13 out of 13 patents)

4.  Patrick W K Lee (12 out of 12 patents)

5.  Donald Morris (8 out of 8 patents)

6.  Leo Pavliv (4 out of 38 patents)

7.  Sarah Serl (4 out of 4 patents)

8.  Patrick W Lee (2 out of 2 patents)

9.  Ramon Alemany Bonastre (1 out of 7 patents)

10.  Hardev Pandha (1 out of 3 patents)

11.  Mathew C Coffey (1 out of 1 patent)

12.  Manel Maria Piqueras (1 out of 1 patent)

13.  Douglas Ball (1 out of 1 patent)

14.  Kara L Norman (1 out of 1 patent)

15.  Roxna Kapadia (0 patent)


Core Competencies:
Reoviruses
Viral Purification
Oncolytic Therapy
Neoplastic Cells
Cellular Proliferative Disorders
Liquid Viral Formulations
Lyophilized Viral Formulations
Chemotherapeutic Sensitization
Ribozymes
Adenoviruses
Cytokine Production
Virus Clearance

64 patents:

1. 11246930 - Reoviruses having modified sequences (2022-02-15),
2. 10596260 - Reoviruses having modified sequences (2020-03-24),
3. 10167452 - Viral purification methods (2019-01-01),
4. 10039827 - Reoviruses having modified sequences (2018-08-07),
5. 9610352 - Lyophilized viral formulations (2017-04-04),
6. 9610309 - Liquid viral formulations (2017-04-04),
7. 9365823 - Virus clearance of neoplastic cells from mixed cellular compositions (2016-06-14),
8. 9045728 - Liquid viral formulations (2015-06-02),
9. 9044498 - Lyophilized viral formulations (2015-06-02),
10. 8709443 - Reovirus for the treatment of cellular proliferative disorders (2014-04-29),
11. 8691241 - Reoviruses having modified sequences (2014-04-08),
12. 8685734 - Viral purification methods (2014-04-01),
13. 8658158 - Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus (2014-02-25),
14. 8512712 - Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions (2013-08-20),
15. 8491886 - Viruses for the treatment of cellular proliferative disorders (2013-07-23),
Oncolytics Biotech Inc. is a biotechnology company that specializes in the development of oncolytic viruses for the treatment of various types of cancer. Our innovative approach combines genetically engineered viruses with immunotherapeutic agents to selectively target and destroy cancer cells while sparing healthy tissue. With a focus on precision medicine, we strive to provide personalized and effective treatments for patients. Visit our website to learn more about our groundbreaking research and ongoing clinical trials.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
64 Patents

#11 in Calgary

#191 in Canada

#11,029 in the World

...
Calgary, Canada

Oncolytics Biotech Inc.

Forward Citations = 647

14 inventors:

goldMedal Matthew C Coffey (61 out of 64 patents)

silverMedal Bradley G Thompson (32 out of 76 patents)

bronzeMedal James Strong (13 out of 13 patents)

4.  Patrick W K Lee (12 out of 12 patents)

5.  Donald Morris (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com
Loading…